CASE REPORT. Membranoproliferative associated with type II in a renal transplant patient with hepatitis C. Glomerulonefrite membranoproliferativa em. Disease definition. Dense deposit disease, a histological subtype of MPGN (see this term) is an idiopathic chronic progressive kidney disorder distinguished by. Glomerulonefrite membranoproliferativa. Classificação Até achados estruturais e histopatológico fisiopatologia e.

Author: Jut Maule
Country: Guyana
Language: English (Spanish)
Genre: Travel
Published (Last): 14 February 2008
Pages: 127
PDF File Size: 8.58 Mb
ePub File Size: 16.90 Mb
ISBN: 472-3-26706-731-1
Downloads: 93435
Price: Free* [*Free Regsitration Required]
Uploader: Voodookora

Kidney Int ;69 3: Rituximab induces regression of hepatitis C virus-related membranoproliferative in a renal allograft. His maintenance immunosuppressive treatment consisted of tacrolimus AdvagrafR 5. Summary and related texts. In September glomerulonnefrite, his SCr raised to 1.

Glomerulonefrite membranoproliferativa by Isabela Alcântara on Prezi

The allograft biopsy showed lesions compatible with membranoproliferativewith staining in the immunofluorescence for granular IgM and C3 and no C4d. A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection. Patients from the Renal Membranoproliferafiva of the Flomerulonefrite University of Bahia, Brazil, 80 with focal segmental glomerulosclerosis FSG and 50 with membranoproliferative glomerulonephritis MPGN were compared regarding the distribution of the racial types black, mulatto, white.

Membranoproliferative associated with type II in a renal transplant patient with hepatitis C. Hepatitis C virus infection as a risk factor for graft loss after renal transplantation In: The documents contained in this web site are presented for information purposes only. Hepatitis C virus-associated membranoproliferative glomerulonephritis in renal allografts. Treatment of hepatitis C-virus related. The management is critical and the main purpose is to improve long-term allograft survival.


Am J Transplant ;1 2: Kidney Int ;77 8: Am J Kidney Dis ;46 4: Clin J Am Soc Nephrol ;2 3: Rituximab treatment for glomerulonefritis in HCV-associated mixed cryoglobulinaemia: The patient did not receive any previous antiviral therapy.

An allograft biopsy was performed and showed lesions compatible with MPGN. Only comments written in English can be processed. In our case, the treatment with rituximab resulted in a favourable outcome, although a longer follow-up period may be needed to evaluate the clinical response, since other studies reported high relapse rates. The data support the possibility of a greater susceptibility to FSG among negroes and mulattoes, independently of age, gender and schistosomiasis.

Nephrol Dial Transplant ;21 8: Crioglobulinemia; glomerulonefrite membranoproliferativa; hepatite C; rituximab; transplante renal. Iran J Kidney Dis ;4 1: J Am Soc Nephrol ;7 Rituximab, a human mouse chimeric monoclonal antibody directed against CD20 antigen on B lymphocytes, has recently proved to be effective on the treatment of this entity, however, the ideal dosage of this drug has not yet been defined.

His baseline serum creatinine SCr was 1.

Hepatitis C virus infection in nephrology patients. Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. Other search option s Alphabetical list. The material is in no way intended to replace professional medical care by a qualified specialist and should hlomerulonefrite be used as a basis for diagnosis or treatment.

Hepatitis C infection in kidney transplantion. Two months after the last dose of rituximab, hypertension resolved, serum creatinine improved 1.


Glomerulonefrite membranoproliferativa

Specialised Social Services Eurordis directory. Higher HCV viral loads may result in more immune complexes and increased deposition of viral complexes in the kidney and a higher risk for HCV-related nephropathy 1,13 on the contrary, a sustained virological response serum HCV-RNA undetectable may reduce post-transplant recurrence of HCVas well as chronic allograft nephropathy 1,13, All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License.

Os exames laboratoriais demonstraram: Clin Transplant ;20 6: Clin J Am Soc Nephrol ;4 1: Treatment of this entity is a complex issue, nonconsensual and represents a challenge to clinicians.

The treatment of this entity is a complex, nonconsensual issue glomerylonefrite represents a challenge to clinicians. Os anticorpos antinuclear e anti-double stranded DNA foram negativos.

There were no other organ manifestations of. This form often has a higher recurrence rate after a kidney transplant and is associated with extra-renal manifestations such as familial drusen see this term. However, a longer follow-up period post-therapy 12 months is needed to evaluate clinical response, since the relapse rate may be high. Kidney Int Suppl ; According to KDIGO clinical practice guidelines oftreatment with interferon should be reserved to patients with fibrosing cholestatic hepatitis or life-threatening vasculitis The treatment of this entity is not consensual and represents a challenge to clinicians.